In LC A549 cells, curcumin suppressing cell migration and invasion by inhibiting adiponectin through NF-κB/MMP pathways, indicating that targeting NF-κB/MMP pathways might be an alternative for adjuvant therapy in LC patients (65). The gene discussed is ADIPOQ; the disease is laryngotracheoesophageal cleft.